These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22134931)

  • 1. Post-shingles neuralgia by any definition is painful, but is it PHN?
    Yawn BP
    Mayo Clin Proc; 2011 Dec; 86(12):1141-2. PubMed ID: 22134931
    [No Abstract]   [Full Text] [Related]  

  • 2. Community and patient values for preventing herpes zoster.
    Lieu TA; Ortega-Sanchez I; Ray GT; Rusinak D; Yih WK; Choo PW; Shui I; Kleinman K; Harpaz R; Prosser LA
    Pharmacoeconomics; 2008; 26(3):235-49. PubMed ID: 18282017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Herpes zoster in old adults].
    Lang PO; Belmin J; Michel JP
    Presse Med; 2009 Apr; 38(4):571-83. PubMed ID: 19028069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zoster vaccine protects against shingles.
    BMJ; 2013 Apr; 346():f2389. PubMed ID: 23596220
    [No Abstract]   [Full Text] [Related]  

  • 5. Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster Vaccine.
    Tseng HF; Lewin B; Hales CM; Sy LS; Harpaz R; Bialek S; Luo Y; Jacobsen SJ; Reddy K; Huang PY; Zhang J; Anand S; Bauer EM; Chang J; Tartof SY
    J Infect Dis; 2015 Oct; 212(8):1222-31. PubMed ID: 26038400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of herpes zoster and its painful and debilitating complications.
    Johnson R; McElhaney J; Pedalino B; Levin M
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S43-8. PubMed ID: 18162246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination against Herpes Zoster and Postherpetic Neuralgia.
    Oxman MN; Levin MJ;
    J Infect Dis; 2008 Mar; 197 Suppl 2(Suppl 2):S228-36. PubMed ID: 18419402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes Zoster (Shingles).
    Bolton L
    Wounds; 2018 May; 30(5):144-146. PubMed ID: 29847305
    [No Abstract]   [Full Text] [Related]  

  • 9. Herpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic neuralgia in an older US population: a cohort study.
    Langan SM; Smeeth L; Margolis DJ; Thomas SL
    PLoS Med; 2013; 10(4):e1001420. PubMed ID: 23585738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia.
    Betts RF
    J Am Acad Dermatol; 2007 Dec; 57(6 Suppl):S143-7. PubMed ID: 18021866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine against herpes zoster halves incidence in older people, finds study.
    Ramsey S
    BMJ; 2013 Apr; 346():f2349. PubMed ID: 23585074
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study tests Varicella-Zoster vaccine for over 60-years-old persons. Protection from Herpes zoster and postherpetic neuralgia].
    MMW Fortschr Med; 2006; Spec no.1():14-5. PubMed ID: 16872127
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
    Pellissier JM; Brisson M; Levin MJ
    Vaccine; 2007 Nov; 25(49):8326-37. PubMed ID: 17980938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia.
    Holcomb K; Weinberg JM
    J Drugs Dermatol; 2006 Oct; 5(9):863-6. PubMed ID: 17039651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zoster vaccine (Zostavax): a review of its use in preventing herpes zoster and postherpetic neuralgia in older adults.
    Sanford M; Keating GM
    Drugs Aging; 2010 Feb; 27(2):159-76. PubMed ID: 20104941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inadequate evidence for a revised definition of postherpetic neuralgia (PHN).
    Dworkin RH
    Pain; 2007 Mar; 128(1-2):189-90; author reply 190-2. PubMed ID: 17240068
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia.
    Dworkin RH; Gnann JW; Oaklander AL; Raja SN; Schmader KE; Whitley RJ
    J Pain; 2008 Jan; 9(1 Suppl 1):S37-44. PubMed ID: 18166464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early impact of the Australian national shingles vaccination program with the herpes zoster live attenuated vaccine.
    Litt J; Booy R; Bourke D; Dwyer DE; Leeb A; McCloud P; Stein AN; Woodward M; Cunningham AL
    Hum Vaccin Immunother; 2020 Dec; 16(12):3081-3089. PubMed ID: 32420793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zoster vaccine live for the prevention of shingles in the elderly patient.
    Zussman J; Young L
    Clin Interv Aging; 2008; 3(2):241-50. PubMed ID: 18686747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes zoster: diagnostic, therapeutic, and preventive approaches.
    Bader MS
    Postgrad Med; 2013 Sep; 125(5):78-91. PubMed ID: 24113666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.